BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, April 3, 2026
Home » Authors » Anette Breindl

Anette Breindl

Articles

ARTICLES

Bench Press: BioWorld looks at translational medicine

June 11, 2018
By Anette Breindl
A team from the Canadian institution The Hospital for Sick Children and the German Cancer Research Center have discovered that antibodies binding to the malaria parasite can interact with each other as well as with their parasite target, and that this interaction improved their affinity for the pathogen. 
Read More

Blood test predicts the chance of preterm labor

June 8, 2018
By Anette Breindl

Blood test predicts preterm labor

June 8, 2018
By Anette Breindl
Two gene expression signatures in blood samples of pregnant women could accurately assess the gestational age of the fetus, and predict which pregnancies would end in preterm birth, respectively.
Read More

Blood stem cell editing enables myeloid cell targeting with CAR T

June 4, 2018
By Anette Breindl

Bench Press: BioWorld looks at translational medicine

June 4, 2018
By Anette Breindl
Early life complications (ELCs) can double the risk of developing schizophrenia, an effect that is greater than that of any common genetic variant. Researchers from the Lieber Institute for Brain Development have discovered that such ELCs affected gene expression in the placenta, and they did so in different ways in the placentas of male and female fetuses. 
Read More

Blood stem cell editing enables myeloid cell targeting with CAR T

June 4, 2018
By Anette Breindl
In the quest to bring chimeric antigen receptor (CAR) T cells to new groups of patients, a lot of work has been focused on engineering the CAR T cells themselves.
Read More

Multitasking nanorobot fights bacterium and its toxin

June 1, 2018
By Anette Breindl

Multitasking nanorobot fights bacterium and its toxin

June 1, 2018
By Anette Breindl
Multiple nanorobots with single functions have been developed in recent years. Now, researchers have created a single nanorobot with multiple functions.
Read More

Bacteria-device combo sheds light in, on the gut

May 29, 2018
By Anette Breindl

New insights may allow treatment, prevention of cytokine release syndrome

May 29, 2018
By Anette Breindl
In medicine, too, there is no free lunch – effective therapies come with side effects. But two new studies could make lunch cheaper for patients treated with chimeric antigen receptor (CAR) T cells. Researchers at the San Raffaele Hospital in Milan, Italy, and the Memorial Sloan Kettering Cancer Center (MSKCC) have gained new insights into the causes of cytokine release syndrome (CRS) and neurotoxicity, the two most serious forms of toxicity that are associated with CAR T cells.
Read More
View All Articles by Anette Breindl

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 2, 2026.
  • Comparison of neurons in a healthy brain and nerve cells in neurodegenerative disease with amyloid plaques

    Small-molecule TREM2 agonist advances to treat Alzheimer’s

    BioWorld Science
    Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
  • Amyloid beta peptides on neurons

    Amlogenyx’s AM-805 reduces amyloid plaques in AD

    BioWorld Science
    The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 31, 2026
  • Atai Therapeutics patents new 5-HT2 receptor agonists

    BioWorld Science
    Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing